logo
Sign In
  1. Home
  2. Indications
  3. Diabetic Nephropathies

Medications for Diabetic Nephropathies

FiltersReset Filters
6 results

  • irbesartan

    (Irbesartan)
    ScieGen Pharmaceuticals, Inc.
    Usage: Irbesartan is indicated for treating hypertension to lower blood pressure, thereby reducing the risk of cardiovascular events. It is also used for managing nephropathy in type 2 diabetic patients with hypertension, elevated serum creatinine, and proteinuria, slowing kidney disease progression.

  • irbesartan

    (IRBESARTAN)
    Jubilant Cadista Pharmaceuticals Inc.
    Usage: Irbesartan tablets are indicated for treating hypertension to lower blood pressure, reducing cardiovascular event risks. They are also approved for diabetic nephropathy in type 2 diabetes patients with hypertension and proteinuria, slowing nephropathy progression.

  • irbesartan

    (IRBESARTAN)
    Alembic Pharmaceuticals Inc.
    Usage: Irbesartan tablets are used to treat hypertension, reducing blood pressure and minimizing the risk of cardiovascular events like strokes and myocardial infarctions. They are also indicated for managing diabetic nephropathy in type 2 diabetes patients with hypertension and significant proteinuria, slowing progression to renal failure.

  • irbesartan

    (IRBESARTAN)
    AvKARE
    Usage: Irbesartan tablets are indicated for treating hypertension to lower blood pressure and reduce cardiovascular event risks, such as strokes and myocardial infarction. Additionally, they are used to treat diabetic nephropathy in type 2 diabetes patients with hypertension and proteinuria, slowing nephropathy progression.

  • losartan potassium

    (Losartan Potassium)
    Unichem Pharmaceuticals (USA), Inc.
    Usage: Losartan potassium is indicated for treating hypertension in adults and pediatric patients (≥6 years), reducing cardiovascular event risks. It also reduces stroke risk in hypertensive patients with left ventricular hypertrophy and treats nephropathy in type 2 diabetic patients with hypertension, lowering progression risks.

  • losartan potassium

    (Losartan)
    Granules India Ltd
    Usage: Losartan potassium is indicated for treating hypertension in adults and children (6 years and older), reducing cardiovascular risks. It also benefits hypertensive patients with left ventricular hypertrophy and treats nephropathy in type 2 diabetic patients with hypertension, slowing progression of kidney disease.
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.